This gene encodes a 105 kD protein which can undergo
cotranslational processing by the 26S proteasome to produce a 50 kD
protein. The 105 kD protein is a Rel protein-specific transcription
inhibitor and the 50 kD protein is a DNA binding subunit of the
NF-kappa-B (NFKB) protein complex. NFKB is a transcription
regulator that is activated by various intra- and extra-cellular
stimuli such as cytokines, oxidant-free radicals, ultraviolet
irradiation, and bacterial or viral products. Activated NFKB
translocates into the nucleus and stimulates the expression of
genes involved in a wide variety of biological functions.
Inappropriate activation of NFKB has been associated with a number
of inflammatory diseases while persistent inhibition of NFKB leads
to inappropriate immune cell development or delayed cell growth.
Two transcript variants encoding different isoforms have been found
for this gene.1) Beshir, A.B., et al. Cancer Lett. 299(2):137-149(2010)
Immunogen
This NFKB(p105) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 911-937 amino acids from the C-terminal region of human NFKB(p105).
Western blot analysis in MDA-MB231 cell line lysates (35ug/lane).This demonstrates the NFKB antibody detected the NFKB protein (arrow).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.